Case Control Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Jan 19, 2025; 15(1): 101186
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.101186
Table 1 Differentially abundant metabolites in patients with schizophrenia with violent aggression
No.
Metabolites
Retention time/minute
m/z
Formula
VIP
P value
Trend
Scan mode
1Platelet-activating factor9.44524.36951C26 H54 N O7 P2.091690.000+
22-amino-1,3,4-octadecanetriol6.441318.29908C18 H39 N O31.881020.000+
3Palmitic acid6.402274.27291C16 H32 O21.868390.000+
4Cortisol5.742363.21555C21 H30 O51.911930.000+
5Stearic acid6.99302.30423C18 H36 O21.595330.000+
6Hexadecanamide10.073256.26277C16 H33 N O1.474240.000+
7Arachidic acid7.54330.33567C20 H40 O21.173540.000+
8N-undecanoylglycine6.134266.17185C13 H25 N O31.979520.000+
9Dihydrosphingosine 1-phosphate7.693382.27068C18 H40 N O5 P1.378630.000+
10Palmitoyl ethanolamide9.734300.28892C18 H37 N O21.707070.000+
11D-(+)-pyroglutamic acid1.01130.04979C5 H7 N O31.210940.000+
12Oleoylethanolamide9.932326.30444C20 H39 N O21.458240.000+
13D-erythro-sphingosine 1-phosphate7.519380.25492C18 H38 N O5 P1.360480.000+
14Hypoxanthine1.111137.04556C5 H4 N4 O1.332420.000+
15Glutamine0.96147.07623C5 H10 N2 O31.241230.000+
16N-undecanoylglycine6.181242.17601C13 H25 N O32.201080.000-
17L-glutamic acid0.893146.0449C5 H9 N O41.91340.000-
18Sphingosine 1-phosphate7.587378.24163C18 H38 N O5 P1.810050.000-
19N-phenylacetylglutamine4.125263.10371C13 H16 N2 O41.688470.000-
20D-(-)-fructose0.853179.05538C6 H12 O61.637290.000-
214-oxoproline0.968128.03417C5 H7 N O31.546290.000-
22L-(+)-lactic acid1.09389.02311C3 H6 O31.166210.000-
23Levothyroxine6.053775.68055C15 H11 I4 N O41.513850.000-
243-hydroxybutyric acid1.784103.03886C4 H8 O31.436350.000-
25Arachidonic acid10.197303.23285C20 H32 O21.122870.000-
26Cis-5,8,11,14,17-eicosapentaenoic acid9.785301.21728C20 H30 O21.098330.000-